Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Development of antagonists that disrupt the hyperactivated camp signalling pathway in immunodeficiencies as immunostimulatory therapy (NEW CAMP ANTAGONISTS)

De 2002-12-01 à 2005-01-31

Détails concernant le projet

Coût total:

EUR 1 901 224

Contribution de l'UE:

EUR 945 844

Coordonné à/au(x)/en:

Norway

Régime de financement:

CRS - Cooperative research contracts

Coordinateur

LAURAS AS
Norway
Gaustadalleen 21
0349 OSLO
Norway
See on map
Contact administratif: Wenche Marie OLSEN

Participants

BIAFFIN GMBH & CO KG
Germany
Universitaetstrasse 150
44870 BOCHUM
Germany
See on map
Contact administratif: Bastian ZIMMERMANN
BIOLOG LIFE SCIENCE INSTITUTE, FORSCHUNGSLABOR UND BIOCHEMICA- VERTRIEB GMBH
Germany
Flughafendamm 9a
28199 BREMEN
Germany
See on map
Contact administratif: Hans-Gottfried GENIESER
UNIVERSITE DE LIEGE
Belgium
Avenue de l'Hopital, 13 bat. B 35
4000 LIEGE
Belgium
See on map
Contact administratif: Willy LEGROS
UNIVERSITY OF KASSEL
Germany
Heinrich Piett Strasse, 40, Raum 2161
34132 KASSEL
Germany
Contact administratif: Manfred NETTEKOVEN
Fax: +38-61-2804484
UNIVERSITY OF OSLO
Norway
Sognvannsveien 9
0317 OSLO
Norway
See on map
Contact administratif: Toril JOHANSSON